Business
Currency:EUR
2024/Q2
Stock NameRevenueRatio
Crop Science4.99B44.77%
Pharmaceuticals4.61B41.40%
Consumer Health1.46B13.10%
All other segments95M0.85%
Enabling Functions and Consolidation-14M-0.13%
Region
Currency:EUR
2023/FY
Stock NameRevenueRatio
United States14.59B30.62%
Europe / Middle East / Africa11.07B23.24%
Brazil4.97B10.43%
Asia / Pacific4.75B9.96%
Latin America3.96B8.31%
China3.62B7.61%
Germany2.45B5.14%
North America1.67B3.50%
Switzerland567M1.19%
View all
